Background The epidemiology of human papillomavirus (HPV) in women has been well
documented. Less is known about the epidemiology of HPV in men. We aim to provide …

Cervical cancer disproportionately affects women of reproductive age, with 80% of cases
occurring in low-and middle-income countries. Persistent infection with high-risk human …

Background Among sub-Saharan African women, cervical cancer is steadily increasing with
more than 75,000 new cases and 50,000 deaths annually. Due to the vast ethno geography …

Introduction. Young women (20‐35 years) are at high risk of HPV infection, although the
majority of the infections are asymptomatic and are cleared spontaneously by the host …

Cervical cancer is a vaccine-preventable sexually transmitted disease. In the year 2020,
there were an estimated 604,000 new cases and 342,000 deaths worldwide. Although its …

Two pathways have been described for vulvar squamous cell carcinomas (VSCC), one
associated with human papillomavirus (HPV), and the other HPV‐independent. We …

Background We conducted in 2018 a descriptive, quantitative, population-based, cross-
sectional survey estimating the prevalence of cervical high-risk human papillomavirus (HR …

Cervical premalignancy/malignancy, as detected by cervical cytology or biopsy, can develop
as a result of human papillomavirus (HPV) infection. Meanwhile, DNA methylation is known …

Abstract Programmed death-ligand 1 (PD-L1) is overexpressed in squamous cervical cancer
(SCC) and can be used for targeted immunotherapy. The highest mortality rates of SCC are …

Purpose Cervical cancer is a major cause of death among women in Eastern Africa, and the
distribution of human papillomavirus (HPV) according to HIV status is inadequately …